Brief: Avenue Therapeutics Says On Nov 20, Staff Formally Notified Co That It Had Determined To Delist Co's Securities From NASDAQ
24/11/2023 18:27
Nov 24 (Reuters) - Avenue Therapeutics Inc ATXI.O :
* AVENUE THERAPEUTICS: ON NOV 20, STAFF FORMALLY NOTIFIED CO
THAT
IT HAD DETERMINED TO DELIST CO'S SECURITIES FROM NASDAQ
* AVENUE THERAPEUTICS INC: INTENDS TO TIMELY REQUEST A
HEARING
BEFORE NASDAQ PANEL, WHICH WILL STAY ANY FURTHER ACTION BY
NASDAQ
Further company coverage: ATXI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avenue Therapeutics
See all newsBrief: Axsome Therapeutics Acquires AZD7325, A Selective GABA-A Modulator For Treatment Of Epilepsy
Avenue Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Avenue Therapeutics Annji Intends To Terminate License Agreement With Co
Brief: Avenue Therapeutics Receives Delist Letter From Nasdaq Under Nasdaq Listing Rule 5550(B)(1)
Avenue Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary